Delivery Order SPE2DB20D3303-SPE2DB25FA2LQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for OmniPod Dash Pods (Gen 4) 5-packs valued at $1,030.73. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be performed at the contractor's location in...
- The Defense Logistics Agency awarded a $1,701.90 delivery order to AmerisourceBergen Drug Corp for OmniPod Dash Pods (Generation 4) in five-packs with five units per pack. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child...
- The Defense Logistics Agency awarded a $7,815.50 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for OmniPod Dash Pods (Gen 4) 5-packs. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 22, 2025. The medical supplies will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $3,096.47 delivery order to AmerisourceBergen Drug Corp for OmniPod Dash Pods (Generation 4) 5-packs, with an ultimate completion date of August 5, 2025. This non-competitive delivery order represents a firm fixed price contract and constitutes a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The OmniPod Dash system is a tubeless insulin infusion pump used for diabetes management, and this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OmniPod Dash Pods (Generation 4) in 5-packs on August 7, 2025, with a ceiling value of $1,134.60. This firm fixed price delivery order is scheduled for completion by August 8, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement of specialized medical devices used in insulin delivery systems, supporting...
- The Defense Logistics Agency awarded a $4,727 firm fixed price delivery order to Amerisourcebergen Drug Corporation for five packages of Omnipod Dash Pods (Generation 4). The order was placed under an existing indefinite-delivery/indefinite-quantity contract vehicle to supply medical and pharmaceutical products in support of Department of Defense programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 28, 2023. No subcontractors or set aside...
- The Defense Logistics Agency (DLA) awarded a $1,784.93 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Omnipod Dash Pods (Gen 4) 5-packs. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation, to provide Omnipod Dash Pods (Gen 4) 5-packs. The $2,589.26 award has a completion date of February 1, 2024 and is not set aside for any particular business type. AmerisourceBergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA, valued up to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OMNIPOD DASH PODS (GEN 4) 5PK 5S. The $1,462.24 order has a completion date of January 18, 2024. Amerisourcebergen Drug Corp, as a prime contractor for DLA, has a history of providing pharmaceuticals, medical supplies, and distribution services to support military treatment programs. This delivery order...
- The U.S. federal government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $5,602.01 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to supply Omnipod Dash Pods (Gen 4) 5PK 5S medical devices. This delivery order was issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and runs through...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2LQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for OmniPod Dash Pods (Generation 4) in five-packs, valued at $3,695.75 under firm fixed-price terms. This non-set-aside contract represents a child delivery order executed under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary distribution operations. As a major pharmaceutical and medical device distributor, AmerisourceBergen Drug Corp supplies critical medical commodities to support military healthcare systems worldwide through its prime vendor status with the Defense Logistics Agency. The OmniPod Dash Pods delivery supports federal medical supply needs, specifically for insulin infusion therapy equipment utilized across the Department of Defense healthcare system. This award reflects the company's competitive standing and capability to fulfill specialized medical device requirements through the DLA's established pharmaceutical supply chain framework, which serves military personnel, veterans, and other federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/12/25 |